_2020091018165303jzv.jpg "Decoding The World Of ETF")
-
My Account
My Account
BSE Live
Dec 04, 15:40Prev. Close
1047.40
Open Price
1045.00
Bid Price (Qty.)
1047.00 (25)
Offer Price (Qty.)
1049.70 (26)
NSE Live
Dec 04, 15:56Prev. Close
1047.05
Open Price
1047.05
Bid Price (Qty.)
1049.60 (17)
Offer Price (Qty.)
0.00 (0)
| Yearly Results of Thyrocare Technologies (in Rs. Cr.) | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 | |
| Net Sales/Income from operations | 400.00 | 370.28 | 331.79 | 300.06 | 225.61 | |
| Other Operating Income | -- | -- | -- | -- | 9.52 | |
| Total Income From Operations | 400.00 | 370.28 | 331.79 | 300.06 | 235.14 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 110.17 | 103.25 | 88.07 | 78.38 | 59.66 | |
| Purchase of Traded Goods | 2.25 | 2.33 | 2.41 | 8.64 | 6.64 | |
| Increase/Decrease in Stocks | -0.08 | -0.26 | 0.37 | -0.86 | 0.68 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 45.75 | 40.51 | 32.49 | 29.35 | 24.29 | |
| Depreciation | 19.54 | 14.47 | 12.08 | 11.69 | 11.35 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 75.20 | 76.31 | 69.45 | 67.65 | 49.26 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 147.17 | 133.67 | 126.92 | 105.22 | 83.26 | |
| Other Income | 10.48 | 13.66 | 23.63 | 8.08 | 5.20 | |
| P/L Before Int., Excpt. Items & Tax | 157.65 | 147.33 | 150.56 | 113.30 | 88.46 | |
| Interest | 1.32 | 0.47 | 0.40 | -- | -- | |
| P/L Before Exceptional Items & Tax | 156.33 | 146.86 | 150.16 | 113.30 | 88.46 | |
| Exceptional Items | -44.33 | -- | -2.19 | -- | 0.30 | |
| P/L Before Tax | 112.00 | 146.86 | 147.96 | 113.30 | 88.76 | |
| Tax | 32.68 | 51.63 | 51.93 | 38.45 | 30.00 | |
| P/L After Tax from Ordinary Activities | 79.32 | 95.23 | 96.04 | 74.85 | 58.75 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 79.32 | 95.23 | 96.04 | 74.85 | 58.75 | |
| Equity Share Capital | 52.84 | 52.80 | 53.72 | 53.72 | 53.72 | |
| Reserves Excluding Revaluation Reserves | 321.67 | 399.10 | 400.15 | 364.26 | 321.66 | |
| Equity Dividend Rate (%) | 50.00 | 200.00 | 100.00 | 100.00 | 100.00 | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 15.02 | 17.84 | 17.91 | 13.93 | 11.42 | |
| Diluted EPS | 14.99 | 17.80 | 17.85 | 13.91 | 11.41 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 15.02 | 17.84 | 17.91 | 13.93 | 11.42 | |
| Diluted EPS. | 14.99 | 17.80 | 17.85 | 13.91 | 11.41 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
02.11.2020
Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y
30.10.2020
Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y
08.08.2020
Sell Thyrocare Technologies; target of Rs 307: Prabhudas Lilladher
03.08.2020
Thyrocare Techn Standalone June 2020 Net Sales at Rs 54.40 crore, down 45.87% Y-o-Y
02.11.2020
Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y
30.10.2020
Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y
03.08.2020
Thyrocare Techn Standalone June 2020 Net Sales at Rs 54.40 crore, down 45.87% Y-o-Y
28.05.2020
Thyrocare Techn Standalone March 2020 Net Sales at Rs 93.62 crore, down 3.77% Y-o-Y
